AJOONIAjooni Biotech Ltd.

₹5.1-0.20%

Market Cap

₹0.00 Cr

Stock P/E

0.00

ROCE

0.00%

ROE

0.00%

Book Value

₹0.00

You might have missed

No Recent News

No recent news available for this stock.

Shareholding

Holdings

Distribution

Promoter

Public

Others

From Last Concall

POSITIVES

•
Strong FY24 top-line growth and improving profitability, signaling improving market penetration and cost management.
•
Q4 FY24 quarterly profitability improved sharply, with EBITDA margin at 9.32% and net profit up 68.5% YoY in Q4.

NEGATIVES

•
Execution risk of aggressive growth plan, including capacity expansion and revenue targets with a one-year plant establishment timeline.
•
Promoter stake reduction raises potential alignment concerns; promoters have funded growth via capital raises.

Peers Summary

Deep Value Pick

Ajooni Biotech Ltd. stands out as a potential deep value pick due to its extremely low valuation metrics, despite currently lacking growth and profitability indicators. The analysis of its peers indicates several companies are struggling with profitability, making Ajooni a potentially overlooked option in a financially stressed sector.

Key Points

• Ajooni Biotech Ltd. has a PE ratio of 0.00, indicating a lack of earnings but a potentially low price.
• Mukka Proteins Ltd. shows the highest profitability metrics with a ROE of 27.32%, but is trading at a higher PE ratio of 19.44.
• Waterbase Ltd. is showing negative profitability with the lowest ROE and high debt-to-equity ratio, indicating financial stress.

Top Performers

Mukka Proteins Ltd.

Highest ROE at 27.32% and significant revenue growth over three years (31.72%).

Godrej Agrovet Ltd.

Strong profitability with a ROE of 14.85% and steady EPS growth.

Explore

Watchlists